Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Facial Aesthetics Market, by Product
1.4.2 Europe Facial Aesthetics Market, by Application
1.4.3 Europe Facial Aesthetics Market, by End User
1.4.4 Europe Facial Aesthetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jan – 2022, Mar) Leading Players
Chapter 4. Europe Facial Aesthetics Market by Product
4.1 Europe Dermal fillers Market by Country
4.2 Europe Botulinum toxin Market by Country
4.3 Europe Microdermabrasion Market by Country
4.4 Europe Chemical peels Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Facial Aesthetics Market by Application
5.1 Europe Facial line correction treatment Market by Country
5.2 Europe Scar treatment Market by Country
5.3 Europe Lip enhancement Market by Country
5.4 Europe Restoration of volume or Fullness Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Facial Aesthetics Market by End User
6.1 Europe Hospitals Market by Country
6.2 Europe Specialty & Dermatology Clinics Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Facial Aesthetics Market by Country
7.1 Germany Facial Aesthetics Market
7.1.1 Germany Facial Aesthetics Market by Product
7.1.2 Germany Facial Aesthetics Market by Application
7.1.3 Germany Facial Aesthetics Market by End User
7.2 UK Facial Aesthetics Market
7.2.1 UK Facial Aesthetics Market by Product
7.2.2 UK Facial Aesthetics Market by Application
7.2.3 UK Facial Aesthetics Market by End User
7.3 France Facial Aesthetics Market
7.3.1 France Facial Aesthetics Market by Product
7.3.2 France Facial Aesthetics Market by Application
7.3.3 France Facial Aesthetics Market by End User
7.4 Russia Facial Aesthetics Market
7.4.1 Russia Facial Aesthetics Market by Product
7.4.2 Russia Facial Aesthetics Market by Application
7.4.3 Russia Facial Aesthetics Market by End User
7.5 Spain Facial Aesthetics Market
7.5.1 Spain Facial Aesthetics Market by Product
7.5.2 Spain Facial Aesthetics Market by Application
7.5.3 Spain Facial Aesthetics Market by End User
7.6 Italy Facial Aesthetics Market
7.6.1 Italy Facial Aesthetics Market by Product
7.6.2 Italy Facial Aesthetics Market by Application
7.6.3 Italy Facial Aesthetics Market by End User
7.7 Rest of Europe Facial Aesthetics Market
7.7.1 Rest of Europe Facial Aesthetics Market by Product
7.7.2 Rest of Europe Facial Aesthetics Market by Application
7.7.3 Rest of Europe Facial Aesthetics Market by End User
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Acquisition and Mergers:
8.2 Merz Pharma GmbH & Co. KGaA
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.2.2 Product Launches and Product Expansions:
8.3 Galderma S.A.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Approvals and Trials:
8.3.2.3 Acquisition and Mergers:
8.4 Candela Medical Corporation (Syneron Medical Ltd.)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Geographical Expansions:
8.5 Teoxane S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Approvals and Trials:
8.6 Johnson and Johnson
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental &Regional Analysis
8.6.4 Research & Development Expenses
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Ipsen Pharma Biotech SAS
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fotona D.o.o.
8.10.1 Company Overview
Unique Offerings 